Surgical site infections

Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

the AST ID Community of Practice

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

These guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of post-operative surgical site infections (SSIs) in solid organ transplantation. SSIs are a significant cause of morbidity and mortality in SOT recipients. Depending on the organ transplanted, SSIs occur in 3%-53% of patients, with the highest rates observed in small bowel/multivisceral, liver, and pancreas transplant recipients. These infections are classified by increasing invasiveness as superficial incisional, deep incisional, or organ/space SSIs. The spectrum of organisms implicated in SSIs in SOT recipients is more diverse than the general population due to other important factors such as the underlying end-stage organ failure, immunosuppression, prolonged hospitalizations, organ transportation/preservation, and previous exposures to antibiotics in donors and recipients that could predispose to infections with multidrug-resistant organisms. In this guideline, we describe the epidemiology, clinical presentation, differential diagnosis, potential pathogens, and management. We also provide recommendations for the selection, dosing, and duration of peri-operative antibiotic prophylaxis to minimize post-operative SSIs.

Original languageEnglish (US)
Article numbere13589
JournalClinical Transplantation
DOIs
StatePublished - Jan 1 2019

Fingerprint

Surgical Wound Infection
Communicable Diseases
Guidelines
Organ Preservation
Antibiotic Prophylaxis
Organ Transplantation
Infection
Immunosuppression
Pancreas
Epidemiology
Hospitalization
Differential Diagnosis
Tissue Donors
Anti-Bacterial Agents
Morbidity
Mortality
Liver
Population

Keywords

  • antibacterial
  • antibiotic
  • antibiotic prophylaxis
  • infection
  • infectious agents
  • solid organ transplantation
  • surgical infection

ASJC Scopus subject areas

  • Transplantation

Cite this

Surgical site infections : Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. / the AST ID Community of Practice.

In: Clinical Transplantation, 01.01.2019.

Research output: Contribution to journalArticle

@article{c4d32d52e38b474db12b51b221080daa,
title = "Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice",
abstract = "These guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of post-operative surgical site infections (SSIs) in solid organ transplantation. SSIs are a significant cause of morbidity and mortality in SOT recipients. Depending on the organ transplanted, SSIs occur in 3{\%}-53{\%} of patients, with the highest rates observed in small bowel/multivisceral, liver, and pancreas transplant recipients. These infections are classified by increasing invasiveness as superficial incisional, deep incisional, or organ/space SSIs. The spectrum of organisms implicated in SSIs in SOT recipients is more diverse than the general population due to other important factors such as the underlying end-stage organ failure, immunosuppression, prolonged hospitalizations, organ transportation/preservation, and previous exposures to antibiotics in donors and recipients that could predispose to infections with multidrug-resistant organisms. In this guideline, we describe the epidemiology, clinical presentation, differential diagnosis, potential pathogens, and management. We also provide recommendations for the selection, dosing, and duration of peri-operative antibiotic prophylaxis to minimize post-operative SSIs.",
keywords = "antibacterial, antibiotic, antibiotic prophylaxis, infection, infectious agents, solid organ transplantation, surgical infection",
author = "{the AST ID Community of Practice} and Lilian Abbo and Grossi, {Paolo Antonio}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/ctr.13589",
language = "English (US)",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Surgical site infections

T2 - Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

AU - the AST ID Community of Practice

AU - Abbo, Lilian

AU - Grossi, Paolo Antonio

PY - 2019/1/1

Y1 - 2019/1/1

N2 - These guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of post-operative surgical site infections (SSIs) in solid organ transplantation. SSIs are a significant cause of morbidity and mortality in SOT recipients. Depending on the organ transplanted, SSIs occur in 3%-53% of patients, with the highest rates observed in small bowel/multivisceral, liver, and pancreas transplant recipients. These infections are classified by increasing invasiveness as superficial incisional, deep incisional, or organ/space SSIs. The spectrum of organisms implicated in SSIs in SOT recipients is more diverse than the general population due to other important factors such as the underlying end-stage organ failure, immunosuppression, prolonged hospitalizations, organ transportation/preservation, and previous exposures to antibiotics in donors and recipients that could predispose to infections with multidrug-resistant organisms. In this guideline, we describe the epidemiology, clinical presentation, differential diagnosis, potential pathogens, and management. We also provide recommendations for the selection, dosing, and duration of peri-operative antibiotic prophylaxis to minimize post-operative SSIs.

AB - These guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of post-operative surgical site infections (SSIs) in solid organ transplantation. SSIs are a significant cause of morbidity and mortality in SOT recipients. Depending on the organ transplanted, SSIs occur in 3%-53% of patients, with the highest rates observed in small bowel/multivisceral, liver, and pancreas transplant recipients. These infections are classified by increasing invasiveness as superficial incisional, deep incisional, or organ/space SSIs. The spectrum of organisms implicated in SSIs in SOT recipients is more diverse than the general population due to other important factors such as the underlying end-stage organ failure, immunosuppression, prolonged hospitalizations, organ transportation/preservation, and previous exposures to antibiotics in donors and recipients that could predispose to infections with multidrug-resistant organisms. In this guideline, we describe the epidemiology, clinical presentation, differential diagnosis, potential pathogens, and management. We also provide recommendations for the selection, dosing, and duration of peri-operative antibiotic prophylaxis to minimize post-operative SSIs.

KW - antibacterial

KW - antibiotic

KW - antibiotic prophylaxis

KW - infection

KW - infectious agents

KW - solid organ transplantation

KW - surgical infection

UR - http://www.scopus.com/inward/record.url?scp=85066825533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066825533&partnerID=8YFLogxK

U2 - 10.1111/ctr.13589

DO - 10.1111/ctr.13589

M3 - Article

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

M1 - e13589

ER -